Assessment of Safety and Effectiveness in Treatment Management of Paroxysmal Atrial Fibrillation with the BWI Pulsed Field Ablation System with OMNYPULSE™ Catheter (OMNY-AF)
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Heart, Lung and Vascular Research -
Location
-
Principal Investigator
-
Sponsor
Biosense Webster Inc
The primary objective of this clinical investigation is to demonstrate the safety and 12-month effectiveness of the OMNYPULSE™ PFA Platform for pulmonary vein isolation (PVI) in the treatment of subjects with symptomatic paroxysmal atrial fibrillation (PAF).
Enrollment Form
This study is currently enrolling.